12/16/2014 - 12:32pm

Use of cigarettes, alcohol and abuse of prescription pain relievers among teens has declined since 2013, while marijuana use rates were stable, according to the 2014 Monitoring the Future survey, released Tuesday.

12/16/2014 - 12:26pm

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

12/16/2014 - 11:28am

Actavis on Tuesday announced the planned senior management team that will lead the global pharmaceutical company following the successful close of the acquisition of Allergan.

12/16/2014 - 11:14am

Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength. 

 

12/11/2014 - 3:24pm

Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate. 

12/11/2014 - 3:15pm

Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths. 

12/11/2014 - 1:21pm

Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg. 

12/11/2014 - 1:14pm

Mylan on Thursday announced the launch of prednisolone sodium phosphate orally disintegrating tablets in 10-mg, 15-mg and 30-mg dosage strengths. 

 

12/10/2014 - 10:51am

Teva Pharmaceutical Industries on Wednesday announced the launch of generic Celebrex (celecoxib) capsules in the United States. The company is offering the capsules in 50-,100-, 200- and 400-mg dosage strengths.